Manage Your Liver
Q:

What liver doctors will not tell you: Killing the virus will not make you healthy

What liver doctors will not tell you: Killing the virus will not make you healthy
A:

For many years, countries around the world have actively studied and invested in developing new drugs for hepatitis C, hoping to come up with a cure that can kill the virus. This effort has resulted in the launch of new direct antiviral DDAs drugs, which have a higher success rate than the conventional interferon treatment. [1] However, should this so-called high success rate be the focus point for patients? Is successfully getting rid of the viruses enough?

 

For hepatitis patients, the ultimate aim and wish should be to stop inflammation in the liver, to repair liver function (normalise ALT level), and to get their health back! In addition, the treatment should have quick results, no side effects, and financially affordable by the general public! But how beneficial is the currently over-promoted so-called ideal drug for hepatitis C to the patient’s health? Can these new drugs ensure recovery of liver health? Does it have any side effects? Can patients afford its ridiculous price?

 

The truth is, it is possible to eradicate the hepatitis C virus by medications and drug treatment, however this does not guarantee stopping inflammation in the liver, recovering normal liver function, nor making the body healthier. In fact, these new drugs only guarantee the patients different degrees of side effects during or even after treatment. [2] 

 

All kinds of medications can cause harm to our bodies, especially the kidneys and liver. DDAs are no exception; patients receiving treatment will certainly experience and be affected by side effects. [3] During the treatment process, the drugs might lower the viral count, but at the same time continue to damage the liver and overall health. Suppose the drugs have a 100% success rate, but if health and normal liver function cannot be guaranteed after treatment, is this result worth paying such a high price for?

 

Some patients shared their views about post treatment side effects (Fig. 1):

  • I also have 0 Viral (load) thanks to sovaldi. I’ve been free (of hepatitis C) since Aug 2014. But (I) am having a lot of (other) med problems. So far hard to say they are not related. I don't know.
  • I’m still dealing with the side effects of the interferon and ribavirin I took in 2002. (written in 2016)

 

 

Fig. 1 

 

Our bodies do not lie. In fact, after using drug treatment, even if the virus no longer exists in the body, normal liver function is not guaranteed. Patients may still suffer from different problems due to side effects.

 

Those who have similar experience, why not share your view with others? Did your liver health return to normal after treatment? Do you think you are healthy now? Do any side effects persist?

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us